Monday, January 08, 2007

Acting CMS Chief Expresses Doubt About HR 4

The Washington Post reports that Acting Centers for Medicare and Medicaid Services Administrator Leslie Norwalk expressed doubts about the value of the bill -- H.R. 4 -- that would authorize her agency to negotiate Medicare Part D drug prices with manufacturers, echoing criticisms published in yesterday's New York Times (see 1/7 FEHBlog entry). The Department of Health and Human Services announced today that the current competitive system under which the private Medicare Part D drug plan sponsors negotiate with the manufacturers is producing lower Medicare Part D program costs. Of course, the sponsors of HR 4 beg to differ. The bill is expected to be put to vote on January 12 pursuant to Section 510 of H. Res. 6, which the House passed on January 5.

No comments: